Tuesday, January 20, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research ...

Absci (NASDAQ:ABSI) used a presentation at the 44th JPMorgan Healthcare Conference to outline recent platform updates and ...

Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...

A newly revealed customs contract shows US Border Patrol has a £55,000 ($75,000) taxpayer-funded deal with Four Seasons Pet ...

Leveraging modular gene editors and new regulatory pathways, Aurora will develop and commercialize therapies that can be rapidly tailored to many rare variants -- Founded by CRISPR pioneers Jennifer ...

The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Kara Burnstine, M.S., R.D.N., L.D.N., C.D.C.E.S. Nutrition / Weight Loss / Diabetes / Cardiovascular Health / Gut Health Kara Burnstine has over 20 years of ...